Riskpilot← Back to searchSign inGet full accessAkira Science AB
ABActiveOrg 5591934764Hornsgatan 119Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20191-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+205% vs 2023
Equity ratio
22.4%
Financial strength
Net profit 2024
SEK 100K
+202% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 102K | +205% |
| Net profit | SEK 100K | +202% |
| Total assets | SEK 883K | +188% |
| Equity | SEK 197K | +104% |
| Employees | — | — |
Legal name
Akira Science AB
Org number
5591934764
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
4 februari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Akira science ska bedriva forskning, utveckling, produktion och handel med polymerbaserade produkter, företrädesvis nedbrytbara sådana samt sådana som är lämpade för biologiskt relaterade tillämpingar. Verksamheten ska bedrivas inom branscherna kommersiell och akademisk forskning och utveckling, medicin, biomedicin, sjukvård, bioteknik, kemi, miljö och hälsa. Företaget kommer även att bedriva utvecklingsprojekt och konsultverksamhet inom ovan nämnda branscher samt därmed förenlig verksamhet.
Address
Hornsgatan 119
Email
alvaro@akirascience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | — | 123 | 0 | 0 |
| Staff expenses | — | — | — | −262 | −253 |
| EBITDA | −4 | 0 | 187 | −97 | 102 |
| Depreciation & amort. | −0 | — | −0 | — | — |
| EBIT | −4 | 0 | 187 | −97 | 102 |
| Net financials | — | — | — | −2 | 4 |
| Profit before tax | −4 | 0 | 187 | −99 | 106 |
| Tax | −0 | — | −29 | — | −6 |
| Net profit | −4 | — | 158 | −99 | 100 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 45 | — | 435 | 306 | 883 |
| Equity | 45 | — | 196 | 97 | 197 |
| Long-term debt | 0 | — | 0 | — | 500 |
| Short-term debt | 0 | — | 240 | 209 | 186 |
| Total debt | — | — | 240 | 209 | 686 |
EBITDA margin
10198300.0%
This company
15.8%
Market median
+64546103% vs market
20202024
Equity ratio
22.4%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
50.9%
This company
18.4%
Market median
+177% vs market
20202024
Net profit margin
10048800.0%
This company
8.1%
Market median
+124059159% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
3.47×
This company
0.62×
Market median
-460% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Former (3) | ||
| Chairman | 2021 – 2022 | |
| Deputy Board Member | 2025 – 2026 | |
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Akira Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alvaro Morales Lopez | Chief Executive Officer | 0 companies |
| Anna Maria Finne Wistrand | Chief Executive Officer | 0 companies |
| Tiziana Fuoco | Chairman | 0 companies |
| Veluska Gabriela Arias Goa Bruce | Board of Directors | 0 companies |
| Javier de la Rua Martinez | Deputy Board Member | 0 companies |
| Ana Catarina De Araújo Silva | Chairman | 0 companies |
| Daniela Pappalardo | Board of Directors | 0 companies |